{"mainPropery":{"diseaseId":7615,"diseaseName":"Scleromyxedema","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7615/scleromyxedema","synonyms":["Arndt-Gottron disease","Generalized lichenoid papular eruption","Generalized papular and sclerodermoid ","Generalized papular and sclerodermoid lichen myxedematosus"],"synonyms-with-source":[{"name":"Arndt-Gottron disease","source":"Oprhanet"},{"name":"Generalized lichenoid papular eruption","source":"Orphanet"},{"name":"Generalized papular and sclerodermoid ","source":"Orphanet"},{"name":"Generalized papular and sclerodermoid lichen myxedematosus","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"167635"},{"identifierType":"UMLS","identifierId":"C0263390"}]},"diseaseCategories":[{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":310,"resourceName":"Scleromyxedema Survivors","address1":"C/O Phyllis Kay Phillips","address2":"1704 Lower Millstone Lane","address3":"","address4":"","address5":"","city":"Salisbury","state":"MD","zip":"21801 ","country":"United States","phone":"410-742-7843 ","tty":"","tollFree":"","fax":"","email":"","url":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=scleromyxedema%20%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Scleromyxedema. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":189,"resourceId":1036,"resourceName":"Scleromyxedema Support Group","descriptionText":"Visit the <a href='http://www.facebook.com/groups/295129653918238/ ' target='_blank'>Scleromyxedema group</a> on Facebook.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":190,"resourceId":1036,"resourceName":"Scleromyxedema Support Group","descriptionText":"A <a href='http://health.groups.yahoo.com/group/scleromyxedema/ ' target='_blank'>Scleromyxedema Yahoo group</a> is available as an onlineÂ community for people with scleromyxedema.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1074545-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=167635' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://dermnetnz.org/immune/scleromyxoedema.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:167635' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1475,"questionText":"What is scleromyxedema?","answerText":"<strong>Scleromyxedema</strong> is a rare, severe skin disorder. Signs and symptoms include abnormal accumulation of mucin in the skin (<a href=\"http://dermnetnz.org/immune/mucinoses.html\" target=\"_blank\">mucinosis</a>), causing <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0003717/\" target=\"_blank\">papular</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/scleroderma.html\" target=\"_blank\">sclerodermoid</a> bumps; increased production of fibroblasts (connective tissue cells) in the absence of a thyroid disorder; and <a href=\"https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=134&amp;ContentID=121\" target=\"_blank\">monoclonal gammopathy</a> (abnormal proteins in the blood). It often involves internal organs and may affect various body systems.[7362][7363] The  cause of scleromyxedema is not known. There is no standard treatment. Management may involve the use of <a href=\"http://dermnetnz.org/treatments/immunoglobulin.html\" target=\"_blank\">intravenous immunoglobulin (IVIG)</a>,&nbsp;<a href=\"http://www.hopkinsmedicine.org/transplant/programs/kidney/incompatible/plasmapheresis.html\" target=\"_blank\">plasmapheresis</a>, <a href=\"https://medlineplus.gov/druginfo/meds/a699032.html\" target=\"_blank\">thalidomide </a>and <a href=\"http://my.clevelandclinic.org/health/drugs_devices_supplements/hic_Corticosteroids\" target=\"_blank\">corticoids</a>, or more aggressive interventions, such as <a href=\"https://medlineplus.gov/ency/article/003009.htm\" target=\"_blank\">autologous bone marrow transplantation</a>.[7363]","dateModified":"2016-09-29T00:00:00"},"basicQuestions":[{"questionId":1476,"questionText":"What are the signs and symptoms of scleromyxedema?","answerText":"Scleromyxedema usually affects people between the ages of 30 and 50.[876] Skin symptoms usually include a generalized papular eruption with sclerosis (hardening of tissue).&nbsp; <br />\r\n<br />\r\nThe papules may be dome shaped, firm, skin colored, or red, and approximately 3 mm in diameter.&nbsp; Extensive areas of the skin may be involved. The&nbsp;face, knees, and elbows are often affected and the range of motion of the face, fingers, and extremities is decreased.<br />\r\n<br />\r\nScleromyxedema can involve areas of the body other than the skin, including the pharynx and the upper airway. Other symptoms that can be caused by scleromyxedema include:\r\n<ul>\r\n    <li>Esophageal aperistalsis (absence of muscular contractions that help us swallow)&nbsp;&nbsp;\r\n    </li>\r\n    <li>Hoarseness&nbsp;&nbsp;\r\n    </li>\r\n    <li>Inflammatory polyarthritis (simultaneous inflammation of several joints)&nbsp;\r\n    </li>\r\n    <li>Proximal myopathy (various conditions or diseases of the muscular tissues)&nbsp;\r\n    </li>\r\n    <li>Neurologic dysfunction&nbsp;\r\n    </li>\r\n    <li>Eye abnormalities</li>\r\n    <li>Breathing difficulty caused by <a href=\"http://www.webmd.com/lung/obstructive-and-restrictive-lung-disease\" target=\"_blank\">restrictive and obstructive pulmonary dysfunction</a></li>\r\n    <li>Heart abnormalities.</li>\r\n</ul>\r\n<div class=\"AdUnit\" id=\"ads-pos-520\" style=\"display: none;\" data-google-query-id=\"CLvblNLqtc8CFVQSgQodxVwItA\">\r\n<div id=\"google_ads_iframe_/4312434/profpromo/medscprefdesktop_4__container__\" style=\"border: 0pt currentcolor;\"><iframe name=\"google_ads_iframe_/4312434/profpromo/medscprefdesktop_4\" width=\"220\" height=\"5\" title=\"3rd party ad content\" id=\"google_ads_iframe_/4312434/profpromo/medscprefdesktop_4\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" style=\"border: 0px; vertical-align: bottom;\"></iframe>\r\n<br />\r\nGastrointestinal symptoms (most commonly dysphagia) are related to esophageal aperistalsis. Severe proximal muscle weakness, polyarthritis, and symptoms resembling those of organic brain disease are present. Inflammatory myopathy is also reported. Ophthalmologic symptoms include ectropion and corneal opacities. Cardiovascular abnormalities occur in 10% of cases. One study revealed that digital vasoreactivity is the most common vascular abnormality</div>\r\n</div>","dateModified":"2016-09-29T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":876,"authors":"Liotta E.A","articleTitle":"Lichen Myxedematosus","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://www.emedicine.com/DERM/topic231.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1477,"questionText":"What causes scleromyxedema?","answerText":"The underlying cause of scleromyxedema remains unknown.[7363][7362]&nbsp;In a few cases, it has been reported in association with cancers of the bone marrow such as myeloma, lymphoma and leukemia.[7364]","dateModified":"2017-03-13T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":7362,"authors":"Rongioletti F","articleTitle":"Scleromyxedema","bookWebsiteJournalTitle":"UpToDate","date":"2015","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":7363,"authors":"Koronowska SK, Osmola-Mankowska A, Jakubowicz O, Zaba R","articleTitle":"Scleromyxedema: a rare disorder and its treatment difficulties","bookWebsiteJournalTitle":"Postepy Dermatol Alergol","date":"April, 2013","volume":"30(2)","pages":"122-126","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7364,"authors":"Eugene Tan","articleTitle":"Lichen myxoedematosus","bookWebsiteJournalTitle":"DermNet NZ","date":"2008","volume":"","pages":"","url":"http://dermnetnz.org/immune/scleromyxoedema.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7467,"questionText":"Is scleromyxedema inherited?","answerText":"To our knowledge, there is currently no evidence that scleromyxedema is inherited. We are not aware of any reports in the medical literature describing scleromyxedema affecting more than one member of a family.","dateModified":"2017-03-13T00:00:00","resourceClassificationName":"Inheritance","references":[]},{"questionId":1478,"questionText":"How might&nbsp;scleromyxedema be treated?","answerText":"There is no standard treatment for scleromyxedema. The severe course of the disease requires very aggressive treatment, and long-term maintenance therapy is usually necessary. According to the literature, the use of <a href=\"http://dermnetnz.org/treatments/immunoglobulin.html\" target=\"_blank\">intravenous immunoglobilin (IVIG)</a> may be successful and usually is used first; this type of treatment can have relatively long-term effects and few side effects. Because of this, it is currently considered by many the best treatment option. <a href=\"http://www.hopkinsmedicine.org/transplant/programs/kidney/incompatible/plasmapheresis.html\" target=\"_blank\">Plasmapheresis</a> is effective as a short-term treatment but leads to relapses (recurrence of symptoms).[7363] <span>For those patients who cannot receive IVIG,&nbsp;</span><a href=\"https://www-uptodate-com.ezproxy.nihlibrary.nih.gov/contents/thalidomide-drug-information?source=see_link\">thalidomide</a><span>&nbsp;and systemic glucocorticoids </span>may be used. When the patients <span>with severe disease do not have a good response, other interventions are required, such as </span><span><a href=\"https://medlineplus.gov/ency/article/003009.htm\" target=\"_blank\">autologous bone marrow transplantation</a>,&nbsp;</span><a href=\"https://medlineplus.gov/druginfo/meds/a682220.html\" target=\"_blank\">melphalan</a><span>,or&nbsp;</span><a href=\"https://medlineplus.gov/druginfo/meds/a607007.html\" target=\"_blank\">bortezomib</a><span>&nbsp;with&nbsp;</span><a href=\"http://www.webmd.com/drugs/2/drug-1027-5021/dexamethasone-oral/dexamethasone---oral/details\" target=\"_blank\">dexamethasone</a><span>.[7362]&nbsp;</span>","dateModified":"2016-09-29T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":7362,"authors":"Rongioletti F","articleTitle":"Scleromyxedema","bookWebsiteJournalTitle":"UpToDate","date":"2015","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":7363,"authors":"Koronowska SK, Osmola-Mankowska A, Jakubowicz O, Zaba R","articleTitle":"Scleromyxedema: a rare disorder and its treatment difficulties","bookWebsiteJournalTitle":"Postepy Dermatol Alergol","date":"April, 2013","volume":"30(2)","pages":"122-126","url":"","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":45075,"abbreviatedInquiry":"My husband was 43 years old when he died from complications associated with scleromyxedema. We have 2 daughters and one son. Is it hereditary, and should they be tested for the disease?","caseQuestions":[{"questionId":1477,"questionText":"What causes scleromyxedema?","answerText":"The underlying cause of scleromyxedema remains unknown.[7363][7362]&nbsp;In a few cases, it has been reported in association with cancers of the bone marrow such as myeloma, lymphoma and leukemia.[7364]","dateModified":"2017-03-13T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":7362,"authors":"Rongioletti F","articleTitle":"Scleromyxedema","bookWebsiteJournalTitle":"UpToDate","date":"2015","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":7363,"authors":"Koronowska SK, Osmola-Mankowska A, Jakubowicz O, Zaba R","articleTitle":"Scleromyxedema: a rare disorder and its treatment difficulties","bookWebsiteJournalTitle":"Postepy Dermatol Alergol","date":"April, 2013","volume":"30(2)","pages":"122-126","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7364,"authors":"Eugene Tan","articleTitle":"Lichen myxoedematosus","bookWebsiteJournalTitle":"DermNet NZ","date":"2008","volume":"","pages":"","url":"http://dermnetnz.org/immune/scleromyxoedema.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7467,"questionText":"Is scleromyxedema inherited?","answerText":"To our knowledge, there is currently no evidence that scleromyxedema is inherited. We are not aware of any reports in the medical literature describing scleromyxedema affecting more than one member of a family.","dateModified":"2017-03-13T00:00:00","resourceClassificationName":"Inheritance","references":[]},{"questionId":7468,"questionText":"Is genetic testing available for scleromyxedema?","answerText":"No. Genetic testing is not available because the cause of scleromyxedema is not known.","dateModified":"2014-04-18T11:52:00","references":[]}]},{"caseId":22528,"abbreviatedInquiry":"What causes scleromyxedema and how is&nbsp;it treated?","caseQuestions":[{"questionId":1475,"questionText":"What is scleromyxedema?","answerText":"<strong>Scleromyxedema</strong> is a rare, severe skin disorder. Signs and symptoms include abnormal accumulation of mucin in the skin (<a href=\"http://dermnetnz.org/immune/mucinoses.html\" target=\"_blank\">mucinosis</a>), causing <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0003717/\" target=\"_blank\">papular</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/scleroderma.html\" target=\"_blank\">sclerodermoid</a> bumps; increased production of fibroblasts (connective tissue cells) in the absence of a thyroid disorder; and <a href=\"https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=134&amp;ContentID=121\" target=\"_blank\">monoclonal gammopathy</a> (abnormal proteins in the blood). It often involves internal organs and may affect various body systems.[7362][7363] The  cause of scleromyxedema is not known. There is no standard treatment. Management may involve the use of <a href=\"http://dermnetnz.org/treatments/immunoglobulin.html\" target=\"_blank\">intravenous immunoglobulin (IVIG)</a>,&nbsp;<a href=\"http://www.hopkinsmedicine.org/transplant/programs/kidney/incompatible/plasmapheresis.html\" target=\"_blank\">plasmapheresis</a>, <a href=\"https://medlineplus.gov/druginfo/meds/a699032.html\" target=\"_blank\">thalidomide </a>and <a href=\"http://my.clevelandclinic.org/health/drugs_devices_supplements/hic_Corticosteroids\" target=\"_blank\">corticoids</a>, or more aggressive interventions, such as <a href=\"https://medlineplus.gov/ency/article/003009.htm\" target=\"_blank\">autologous bone marrow transplantation</a>.[7363]","dateModified":"2016-09-29T00:00:00","references":[{"referenceId":7362,"authors":"Rongioletti F","articleTitle":"Scleromyxedema","bookWebsiteJournalTitle":"UpToDate","date":"2015","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":7363,"authors":"Koronowska SK, Osmola-Mankowska A, Jakubowicz O, Zaba R","articleTitle":"Scleromyxedema: a rare disorder and its treatment difficulties","bookWebsiteJournalTitle":"Postepy Dermatol Alergol","date":"April, 2013","volume":"30(2)","pages":"122-126","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1476,"questionText":"What are the signs and symptoms of scleromyxedema?","answerText":"Scleromyxedema usually affects people between the ages of 30 and 50.[876] Skin symptoms usually include a generalized papular eruption with sclerosis (hardening of tissue).&nbsp; <br />\r\n<br />\r\nThe papules may be dome shaped, firm, skin colored, or red, and approximately 3 mm in diameter.&nbsp; Extensive areas of the skin may be involved. The&nbsp;face, knees, and elbows are often affected and the range of motion of the face, fingers, and extremities is decreased.<br />\r\n<br />\r\nScleromyxedema can involve areas of the body other than the skin, including the pharynx and the upper airway. Other symptoms that can be caused by scleromyxedema include:\r\n<ul>\r\n    <li>Esophageal aperistalsis (absence of muscular contractions that help us swallow)&nbsp;&nbsp;\r\n    </li>\r\n    <li>Hoarseness&nbsp;&nbsp;\r\n    </li>\r\n    <li>Inflammatory polyarthritis (simultaneous inflammation of several joints)&nbsp;\r\n    </li>\r\n    <li>Proximal myopathy (various conditions or diseases of the muscular tissues)&nbsp;\r\n    </li>\r\n    <li>Neurologic dysfunction&nbsp;\r\n    </li>\r\n    <li>Eye abnormalities</li>\r\n    <li>Breathing difficulty caused by <a href=\"http://www.webmd.com/lung/obstructive-and-restrictive-lung-disease\" target=\"_blank\">restrictive and obstructive pulmonary dysfunction</a></li>\r\n    <li>Heart abnormalities.</li>\r\n</ul>\r\n<div class=\"AdUnit\" id=\"ads-pos-520\" style=\"display: none;\" data-google-query-id=\"CLvblNLqtc8CFVQSgQodxVwItA\">\r\n<div id=\"google_ads_iframe_/4312434/profpromo/medscprefdesktop_4__container__\" style=\"border: 0pt currentcolor;\"><iframe name=\"google_ads_iframe_/4312434/profpromo/medscprefdesktop_4\" width=\"220\" height=\"5\" title=\"3rd party ad content\" id=\"google_ads_iframe_/4312434/profpromo/medscprefdesktop_4\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" style=\"border: 0px; vertical-align: bottom;\"></iframe>\r\n<br />\r\nGastrointestinal symptoms (most commonly dysphagia) are related to esophageal aperistalsis. Severe proximal muscle weakness, polyarthritis, and symptoms resembling those of organic brain disease are present. Inflammatory myopathy is also reported. Ophthalmologic symptoms include ectropion and corneal opacities. Cardiovascular abnormalities occur in 10% of cases. One study revealed that digital vasoreactivity is the most common vascular abnormality</div>\r\n</div>","dateModified":"2016-09-29T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":876,"authors":"Liotta E.A","articleTitle":"Lichen Myxedematosus","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://www.emedicine.com/DERM/topic231.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1477,"questionText":"What causes scleromyxedema?","answerText":"The underlying cause of scleromyxedema remains unknown.[7363][7362]&nbsp;In a few cases, it has been reported in association with cancers of the bone marrow such as myeloma, lymphoma and leukemia.[7364]","dateModified":"2017-03-13T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":7362,"authors":"Rongioletti F","articleTitle":"Scleromyxedema","bookWebsiteJournalTitle":"UpToDate","date":"2015","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":7363,"authors":"Koronowska SK, Osmola-Mankowska A, Jakubowicz O, Zaba R","articleTitle":"Scleromyxedema: a rare disorder and its treatment difficulties","bookWebsiteJournalTitle":"Postepy Dermatol Alergol","date":"April, 2013","volume":"30(2)","pages":"122-126","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7364,"authors":"Eugene Tan","articleTitle":"Lichen myxoedematosus","bookWebsiteJournalTitle":"DermNet NZ","date":"2008","volume":"","pages":"","url":"http://dermnetnz.org/immune/scleromyxoedema.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1478,"questionText":"How might&nbsp;scleromyxedema be treated?","answerText":"There is no standard treatment for scleromyxedema. The severe course of the disease requires very aggressive treatment, and long-term maintenance therapy is usually necessary. According to the literature, the use of <a href=\"http://dermnetnz.org/treatments/immunoglobulin.html\" target=\"_blank\">intravenous immunoglobilin (IVIG)</a> may be successful and usually is used first; this type of treatment can have relatively long-term effects and few side effects. Because of this, it is currently considered by many the best treatment option. <a href=\"http://www.hopkinsmedicine.org/transplant/programs/kidney/incompatible/plasmapheresis.html\" target=\"_blank\">Plasmapheresis</a> is effective as a short-term treatment but leads to relapses (recurrence of symptoms).[7363] <span>For those patients who cannot receive IVIG,&nbsp;</span><a href=\"https://www-uptodate-com.ezproxy.nihlibrary.nih.gov/contents/thalidomide-drug-information?source=see_link\">thalidomide</a><span>&nbsp;and systemic glucocorticoids </span>may be used. When the patients <span>with severe disease do not have a good response, other interventions are required, such as </span><span><a href=\"https://medlineplus.gov/ency/article/003009.htm\" target=\"_blank\">autologous bone marrow transplantation</a>,&nbsp;</span><a href=\"https://medlineplus.gov/druginfo/meds/a682220.html\" target=\"_blank\">melphalan</a><span>,or&nbsp;</span><a href=\"https://medlineplus.gov/druginfo/meds/a607007.html\" target=\"_blank\">bortezomib</a><span>&nbsp;with&nbsp;</span><a href=\"http://www.webmd.com/drugs/2/drug-1027-5021/dexamethasone-oral/dexamethasone---oral/details\" target=\"_blank\">dexamethasone</a><span>.[7362]&nbsp;</span>","dateModified":"2016-09-29T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":7362,"authors":"Rongioletti F","articleTitle":"Scleromyxedema","bookWebsiteJournalTitle":"UpToDate","date":"2015","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":7363,"authors":"Koronowska SK, Osmola-Mankowska A, Jakubowicz O, Zaba R","articleTitle":"Scleromyxedema: a rare disorder and its treatment difficulties","bookWebsiteJournalTitle":"Postepy Dermatol Alergol","date":"April, 2013","volume":"30(2)","pages":"122-126","url":"","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Scleromyxedema"}